Design of a trial evaluating myocardial cell protection with cariporide, an inhibitor of the transmembrane sodium-hydrogen exchanger: the Guard During Ischemia Against Necrosis (GUARDIAN) trial

BACKGROUND: Direct myocardial cell protection in patients with unstable angina or evolving myocardial infarction (MI) could prevent cell necrosis or reduce its extent, and minimize the risk of MI and death associated with percutaneous coronary interventions (PCIs) and coronary artery bypass surgery....

Descripción completa

Detalles Bibliográficos
Autores principales: Theroux, Pierre, Chaitman, Bernard R, Erhardt, Leif, Jessel, Andreas, Meinertz, Thomas, Nickel, Wolf-Ulrich, Schroeder, John S, Tognoni, Gianni, White, Harvey, Willerson, James T
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2000
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC56207/
https://www.ncbi.nlm.nih.gov/pubmed/11714411
http://dx.doi.org/10.1186/cvm-1-1-059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC56207/
https://www.ncbi.nlm.nih.gov/pubmed/11714411
http://dx.doi.org/10.1186/cvm-1-1-059

Ejemplares similares